Abbott Labs unleashes layoffs; Helix Medical buys MedVenture Technology;

 @FierceMedDev: Boston Scientific's Q3 2012 earnings report has very few bright spots, as restructuring continues. More | Follow @FierceMedDev

 @MarkHFierce: Computer viruses are running wild in hospital medical devices, MIT Technology Review reports. More | Follow @MarkHFierce

 @DamianFierce: Stryker is scaling back its profit projections after a disappointing third quarter. More | Follow @DamianFierce

> Abbott Laboratories ($ABT) has laid off an additional 550 people, affecting its diagnostic, medical devices, pharmaceutical and nutrition units. Story

> Paradigm Spine gained FDA approval for a device designed to treat moderate to severe spinal stenosis whether or not back pain is involved. Item

> Helix Medical, a medical device and healthcare industry manufacturer, has acquired MedVenture Technology from private equity firm Ampersand Capital Partners. MedVenture designs, develops and makes medical devices. Neither side disclosed financial terms. Release

> A man with Duchenne muscular dystrophy is among the first U.S. patients with the disease to receive a ventricular assist device. Item

> Neuro Kinetics won a new $2.4 million Department of Defense grant to develop new diagnostic tests for brain injuries stemming from combat. Story

> Device maker Tornier ($TRNX) will announce its 2012 third quarter earnings on Monday, Nov. 5, 2012. Release

> EarlySense gained FDA approval for its new oximetry bedside monitor. Story

> LabCorp ($LH) again reduced its 2012 profit outlook after posting meager growth in the third quarter. Article

Biotech News

 @FierceBiotech: The ax drops on hundreds at Human Genome Sciences in wake of GSK buyout. More | Follow @FierceBiotech

 @JohnCFierce: FDA is extending review of BG-12 (MS). Drat. Thought we'd have an approval this year. Big drug for Biogen. More | Follow @JohnCFierce

> BioCryst scoops up early-stage hep C drugs in $101M Presidio acquisition. Article

> Aegerion wins lopsided FDA panel vote backing rare cholesterol disease drug. News

> Abbott slammed after deaths scuttle PhIII kidney disease program. Story

> Actelion abstract details 'promising' macitentan data. Item

Pharma News

@FiercePharma: NYT explores the sorry state of some pharma manufacturing plants--and their contributions to drug shortages. More | Follow @FiercePharma

> Abbott adds 550 to layoffs toll as split-up nears. Story

> Facing Monday trial, Pfizer settles bellwether Chantix case. Article

> Teva, HGS beef up layoff plans in U.S. News

Vaccines News

> J. Craig Venter explores printable vaccines. Article

> GSK recalls infant vaccine in Australia. Story

> University of Minnesota researchers call for better flu vaccine. More

> Study: HPV vaccine does not increase signs of sexual activity. More

> Special Report: 10 promising therapeutic vaccines 2012. Report

Pharma Manufacturing News

> Ben Venue begins limited manufacturing at Ohio drug plant. News

> Criminal investigators search site linked to meningitis outbreak. Report

> Watson to sell manufacturing tech to seal $5.9B Actavis deal. Story

> FDA warns stem cell outfit Celltex about GMP no-nos. Article

Suggested Articles

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.

The FDA launched a center of excellence to oversee digital health products such as smartphone apps, wearable devices and software-based treatments.

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.